�鶹��Ѱ�����

�鶹��Ѱ�����Boulder Venture Partners awarded Dr. Corrella Detweiler a Translational Therapeutics Accelerator Grant for the proposal “Efflux Pump Inhibitors”. The $50,000 award will be used to develop a new methodology for identifying small molecules that prevent drug resistant bacteria from exporting antibiotics, thus resensitizing them to clinical antibiotics.

To find out more about funding opportunities from Venture Partners, please visit their website at /venturepartners/university-innovators/funding-opportunities-and-support